Measuring how radiation affects vaginal narrowing in cervical cancer
Part of Injuries & trauma clinical trials.
This study measures how radiation therapy changes the vagina’s flexibility and shape in people with newly diagnosed, advanced cervical cancer that has spread to nearby lymph nodes. The goal is to better understand what happens over time, which may help guide prevention and treatment of vaginal narrowing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have newly diagnosed, advanced cervical cancer confirmed by biopsy
- Your cancer has lymph node spread in the pelvis or para-aortic area, located below the T12/L1 level
- You have not had any prior radiation to the pelvis or abdominal/para-aortic area, and no prior cancer treatment for this cancer within the last 3 years
- Blood tests must be strong enough: enough white cells, neutrophils, platelets, and hemoglobin (transfusions before the study are allowed)
- Your kidney, liver, and blood clotting tests must be within allowed limits (or stable if you’re on certain blood thinners)
- If you have HIV, it must be well controlled with stable anti-HIV therapy, a high enough CD4 count, and an undetectable viral load
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help women use vaginal dilators after finishing pelvic radiation for cancers like cervical or anal cancer. It aims to improve vaginal health and quality of life.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
This study tests whether giving a lower radiation dose to the vagina during brachytherapy (internal radiation) is safe and works as well as the standard dose for people with cervical cancer that has not spread to the vagina. It aims to reduce side effects while still treating the cancer effectively.
This trial studies a method to make vaginal dilation easier during pelvic radiotherapy in women with anal cancer. It may help reduce or prevent treatment-related vaginal narrowing and improve comfort and function.
This trial tests whether giving radiation to a smaller area of the pelvis is enough to treat stage IIb cervical cancer, while sparing more healthy tissue. It may help reduce side effects and improve your quality of life during and after treatment.
This trial compares different “fractionation” schedules (how often and how many treatments) of vaginal brachytherapy radiation given after surgery for certain early-stage endometrial cancer. It may help find a plan that works well while aiming to control side effects.
Hear when a new Vaginal Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.